MyChesCo on MSN3mon
FDA Approves New RSV Vaccine for Individuals Aged 50-59
The FDA’s approval of Arexvy for individuals aged 50-59 addresses a critical need in preventing severe respiratory ...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
The Food and Drug Administration expanded the approval of GSK's respiratory syncytial virus vaccine to adults ages 50 to 59 ...
pharmaphorum1d
GSK claims first global approval for an RSV vaccine
The FDA has approved GSK’s Arexvy shot for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older, shortly after it was recommended for ...
BioSpace3d
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
USA Today6d
New eczema drug from Eli Lilly receives FDA approval for children and adults
The FDA's approval was based on three studies involving over 1,000 patients with moderate-to-severe eczema who were ...
Sanofi Says FDA Approves Sarclisa for Treatment of Blood Cancer Patients
Sanofi said the Food and Drug Administration has approved Sarclisa as a first line combined treatment option for adult patients with newly diagnosed multiple myeloma who aren't eligible for autologous ...
FDA Approval Propels ZVRA To 52-week High, ADMA, CPRX, TVTX Also Reach New Peaks
Zevra Therapeutics Inc. (ZVRA) made headlines yesterday with a landmark FDA approval for its innovative drug, MIPLYFFA, in the ...
FDA approves Apple AirPods as hearing aids
The U.S. Food and Drug Administration has authorized the first-ever over-the-counter hearing aid software intended to be used ...